320 related articles for article (PubMed ID: 34940607)
1. New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.
Mace ML; Egstrand S; Morevati M; Olgaard K; Lewin E
Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940607
[TBL] [Abstract][Full Text] [Related]
2. The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization.
Mace ML; Gravesen E; Nordholm A; Egstrand S; Morevati M; Olgaard K; Lewin E
JBMR Plus; 2022 Apr; 6(4):e10610. PubMed ID: 35434452
[TBL] [Abstract][Full Text] [Related]
3. The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.
Hruska KA; Sugatani T; Agapova O; Fang Y
Bone; 2017 Jul; 100():80-86. PubMed ID: 28119179
[TBL] [Abstract][Full Text] [Related]
4. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
[TBL] [Abstract][Full Text] [Related]
5. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
Zhang L; Adu IK; Zhang H; Wang J
Int Urol Nephrol; 2023 Oct; 55(10):2527-2538. PubMed ID: 36964322
[TBL] [Abstract][Full Text] [Related]
6. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
Sugatani T
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
[TBL] [Abstract][Full Text] [Related]
7. Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker.
Williams MJ; White SC; Joseph Z; Hruska KA
Front Physiol; 2023; 14():1120308. PubMed ID: 36776982
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
Brandenburg VM; Verhulst A; Babler A; D'Haese PC; Evenepoel P; Kaesler N
Nephrol Dial Transplant; 2019 Mar; 34(3):408-414. PubMed ID: 29846712
[TBL] [Abstract][Full Text] [Related]
9. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview.
Izzo C; Secondulfo C; Bilancio G; Visco V; Virtuoso N; Migliarino S; Ciccarelli M; Di Pietro P; La Mura L; Damato A; Carrizzo A; Vecchione C
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541742
[TBL] [Abstract][Full Text] [Related]
10. The role of activin: the other side of chronic kidney disease-mineral bone disorder?
Cianciolo G; La Manna G; Capelli I; Gasperoni L; Galassi A; Ciceri P; Cozzolino M
Nephrol Dial Transplant; 2021 May; 36(6):966-974. PubMed ID: 32940690
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder.
Egstrand S; Olgaard K; Lewin E
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):367-377. PubMed ID: 32452917
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.
Aguilar A; Gifre L; Ureña-Torres P; Carrillo-López N; Rodriguez-García M; Massó E; da Silva I; López-Báez V; Sánchez-Bayá M; Prior-Español Á; Urrutia M; Paul J; Bustos MC; Vila A; Garnica-León I; Navarro-González JF; Mateo L; Bover J
Front Physiol; 2023; 14():1177829. PubMed ID: 37342799
[TBL] [Abstract][Full Text] [Related]
13. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
14. Current therapeutic approach of chronic kidney disease-mineral and bone disorder.
Zaimi M; Grapsa E
Ther Apher Dial; 2024 Jun; ():. PubMed ID: 38898685
[TBL] [Abstract][Full Text] [Related]
15. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
[TBL] [Abstract][Full Text] [Related]
16. CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.
Fang Y; Ginsberg C; Seifert M; Agapova O; Sugatani T; Register TC; Freedman BI; Monier-Faugere MC; Malluche H; Hruska KA
J Am Soc Nephrol; 2014 Aug; 25(8):1760-73. PubMed ID: 24578135
[TBL] [Abstract][Full Text] [Related]
17. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
[TBL] [Abstract][Full Text] [Related]
19. Phosphate Balance and CKD-Mineral Bone Disease.
Sprague SM; Martin KJ; Coyne DW
Kidney Int Rep; 2021 Aug; 6(8):2049-2058. PubMed ID: 34386654
[TBL] [Abstract][Full Text] [Related]
20. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
